VantAI
Andrew G. is a Senior AI Scientist at Roivant Sciences, specializing in the design and training of generative AI models for cancer drug discovery. Previously, Andrew G. created a widely used geospatial simulations framework as AgentMaps, and worked as a Machine Learning Engineer at CrisisCamp, where simulations for public relations crises were developed. Early experience includes serving as a Research Engineer at DARPA on a social sciences initiative and founding engineering roles at Piper Learning, Inc., focusing on educational gaming products. Andrew G. holds an education from The City University of New York.
This person is not in the org chart
VantAI
1 followers
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods.